Krisnamurti Desak Gede Budi, Farida Siti, Putri Rizky Clarinta, Fachri Wilzar, Purwaningsih Erni Hernawati
Department of Medical Pharmacy, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
Drug Development Research Cluster, Indonesia Medical Education and Research Institute (IMERI), Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
J Adv Vet Anim Res. 2022 Jun 30;9(2):346-350. doi: 10.5455/javar.2022.i601. eCollection 2022 Jun.
The study aimed to determine the effect of Linn. (AI) root extract and a combination of simvastatin-AI on improving the fatty pancreas in Sprague-Dawley rats induced with a high fructose and cholesterol diet.
Twenty-four male Sprague-Dawley rats were induced with a high fructose and cholesterol diet for 4 weeks before being divided into four groups. Each group receiving treatments consisting of simvastatin only, extracts only, or simvastatin- extract combination. A histological examination was conducted to determine the effect of each treatment. Also, one-way analysis of variance (ANOVA) and Bonferroni test were conducted to assess the comparison of groups from the histological examination.
Significant improvement was found in fatty pancreas between rats without therapy and rats treated with simvastatin therapy ( = 0.024, 95% CI: 0.038-0.696), and also between rats without treatment and rats treated with simvastatin- extract combination therapy ( = 0.000, 95% CI: 0.241-0.873) using one-way ANOVA and the Bonferroni test.
The results of the combination of simvastatin- Linn. root extracts treatment showed a synergistic effect on the improvement of fatty pancreas, but further research is needed to find potential adverse effects on the interaction of these two substrates to confirm the safe use of this treatment.
本研究旨在确定Linn.(AI)根提取物以及辛伐他汀与AI的组合对改善高果糖和胆固醇饮食诱导的Sprague-Dawley大鼠脂肪胰腺的作用。
24只雄性Sprague-Dawley大鼠在高果糖和胆固醇饮食诱导4周后被分为四组。每组接受仅辛伐他汀、仅AI提取物或辛伐他汀与AI提取物组合的治疗。进行组织学检查以确定每种治疗的效果。此外,进行单因素方差分析(ANOVA)和Bonferroni检验以评估组织学检查中各组之间的比较。
使用单因素方差分析和Bonferroni检验发现,未治疗的大鼠与接受辛伐他汀治疗的大鼠之间( = 0.024,95% CI:0.038 - 0.696)以及未治疗的大鼠与接受辛伐他汀与AI提取物联合治疗的大鼠之间( = 0.000,95% CI:0.241 - 0.873)的脂肪胰腺有显著改善。
辛伐他汀与**Linn.**根提取物联合治疗的结果显示对改善脂肪胰腺有协同作用,但需要进一步研究以发现这两种底物相互作用的潜在不良反应,以确认这种治疗的安全使用。